Decreased ADAMTS13 activity has been demonstrated in patients with HIV infection who have thrombotic thrombocytopenic purpura, possibly because endothelial production of ADAMTS13 by HIV-infected endothelial cells is decreased or because ... Antiretroviral
The fixed-dose tablet is indicated for adults with HIV-1 infection whose virus is suppressed on a stable regimen for at least six months, with no history of treatment failure. ... A trial of 1,024 patients found that those who switched to the regimen
The cobas TaqScreen MPX Test, the first to screen for the presence of two divergent types of HIV in donated blood plasma and tissue.
Ongoing monitoring of patients' CD4 cell count, HIV-1 RNA levels, ART adherence, HIV-drug resistance, and quality-of-care indicators is recommended. ... In the same issue of JAMA, researchers reported that HIV-infected and uninfected women with a normal
In last week's ACP HospitalistWeekly, the headline of an item on tuberculosis prevention in HIV patients should have read “WHO issues guidelines on TB prevention in people with HIV in ... In last week's ACP HospitalistWeekly, the headline of the item
Over the next 6 months, all participants were screened for Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum (syphilis), herpes simplex virus 2 and HIV, as well as Trichomonas vaginalis in women. ... sample. Prevention counseling
The November/December issue of ACP Internist is now online, featuring stories on medical residency, HIV, and more. ... Medical issues have since grown more complex as doctors consider how HIV interacts with aging and how aging interacts with these
It is the first FDA-approved diagnostic that differentiates between HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigen in human serum or plasma specimens. ... Reporting of distinct results also helps differentiate between acute and established HIV
HIV-positive patients, pregnant patients, patients with primary burn injuries, patients receiving steroids and patients who could not give informed consent were excluded.
Even if one or more regimens has failed, the therapeutic goal should still be undetectable plasma HIV-1 RNA levels. ... When changing regimens, consider the stage of HIV, nadir and current CD4 cell count, comorbidities, treatment history, current and